| Cancer-related molecular mechanisms research | Lifetime | 19 | US 8 | 99.84 |
| Cancer Genomics and Diagnostics | Lifetime | 81 | US 51 | 99.77 |
| Molecular Biology Techniques and Applications | Lifetime | 51 | US 35 | 99.36 |
| RNA modifications and cancer | Lifetime | 209 | US 116 | 99.44 |
| Prostate Cancer Treatment and Research | Lifetime | 147 | US 89 | 99.47 |
| Gene expression and cancer classification | Lifetime | 74 | US 46 | 98.83 |
| MicroRNA in disease regulation | Lifetime | 389 | US 125 | 98.65 |
| Cell death mechanisms and regulation | Lifetime | 136 | US 57 | 98.86 |
| RNA Research and Splicing | Lifetime | 479 | US 296 | 98.59 |
| Cancer Mechanisms and Therapy | Lifetime | 194 | US 96 | 97.91 |
| interferon and immune responses | Lifetime | 349 | US 155 | 97.65 |
| Cancer-related gene regulation | Lifetime | 444 | US 214 | 97.79 |
| Bioinformatics and Genomic Networks | Lifetime | 307 | US 145 | 97.58 |
| Cancer, Lipids, and Metabolism | Lifetime | 545 | US 271 | 97.99 |
| Protein Degradation and Inhibitors | Lifetime | 328 | US 185 | 97.38 |
| Single-cell and spatial transcriptomics | Lifetime | 299 | US 172 | 96.11 |
| Genetic factors in colorectal cancer | Lifetime | 871 | US 366 | 97.26 |
| Cancer-related Molecular Pathways | Lifetime | 913 | US 459 | 97.10 |
| Ubiquitin and proteasome pathways | Lifetime | 899 | US 433 | 96.52 |
| Circular RNAs in diseases | Lifetime | 812 | US 141 | 95.73 |
| Genomics and Rare Diseases | Lifetime | 563 | US 270 | 95.99 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 954 | US 453 | 97.17 |
| PARP inhibition in cancer therapy | Lifetime | 920 | US 386 | 91.24 |
| Cancer Genomics and Diagnostics | 2021-2025 | 139 | US 72 | 98.92 |
| Prostate Cancer Treatment and Research | 2021-2025 | 619 | US 218 | 94.71 |
| Protein Degradation and Inhibitors | 2021-2025 | 540 | US 235 | 90.01 |
| Single-cell and spatial transcriptomics | 2021-2025 | 742 | US 327 | 87.64 |
| Ubiquitin and proteasome pathways | 2021-2025 | 729 | US 184 | 84.10 |
| PARP inhibition in cancer therapy | 2021-2025 | 877 | US 304 | 79.46 |
| Cancer-related Molecular Pathways | 2021-2025 | 666 | US 216 | 76.64 |
| Cancer Mechanisms and Therapy | 2021-2025 | 975 | US 134 | 71.44 |
| Chromatin Remodeling and Cancer | 2021-2025 | 472 | US 199 | 67.43 |
| FOXO transcription factor regulation | 2021-2025 | 397 | US 105 | 38.21 |
